Missing transverse energy performance of the CMS detector

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Physical, Thermal and Water-Sorption Properties of Passion Fruit Seeds

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

White Noise e Cosmopolis: análise do processo de desumanização em ficções pós-modernas

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Estudo do ultrassom de potência no pré-tratamento do material lignocelulósico de resíduos da bananeira

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Microencapsulation of turmeric oleoresin in binary and ternary blends of gum arabic, maltodextrin and modified starch

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Influence of alternative drying aids on water sorption of spray dried mango mix powders: a thermodynamic approach

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

The effect of power-ultrasound on the pretreatment of acidified aqueous solutions of banana flower-stalk: Structural, chemical and statistical analysis

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Adalimumab for maintenance therapy for one year in Crohn's disease: results of a Latin American single-center observational study

Adalimumab is a fully-human antibody that inhibits TNF alpha, with a significant efficacy for long-term maintenance of remission. Studies with this agent in Latin American Crohn's disease patients are scarce. The objective of this study was to outline clinical remission rates after 12 months of adalimumab therapy for Crohn's disease patients. Retrospective, single-center, observational study of a Brazilian case series of Crohn's disease patients under adalimumab therapy. Variables analyzed: demographic data, Montreal classification, concomitant medication, remission rates after 1, 4, 6 and 12 months. Remission was defined as Harvey-Bradshaw Index ≤ 4, and non-responder-imputation and last-observation-carried-forward analysis were used. The influence of infliximab on remission rates was analyzed by Fischer and Chi-square tests (P<0.05). Fifty patients, with median age of 35 years at therapy initiation, were included. Remission rates after 12 months of therapy were 54% under non-responder-imputation and 88% under last-observation-carried-forward analysis. After 12 months, remission on patients with previous infliximab occurred in 69.23% as compared to 94.59% in infliximab-naïve patients (P = 0.033). Adalimumab was effective in maintaining clinical remission after 12 months of therapy, with an adequate safety profile, and was also more effective in infliximab naïve patients.

Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review

To re-evaluate the safety of hormonal contraceptives (HC) after uterine evacuation of complete hydatidiform mole (CHM). Historical database review. Charing Cross Hospital Gestational Trophoblastic Disease Centre, London, United Kingdom. Two thousand four hundred and twenty-three women with CHM of whom 154 commenced HC while their human chorionic gonadotropin (hCG) was still elevated, followed between 2003 and 2012. We compared time to hCG remission between HC users and nonusers. The relationship between HC use and gestational trophoblastic neoplasia (GTN) development was assessed. The relationship between HC use and a high International Federation of Gynecology and Obstetrics (FIGO) risk score was determined. Time to hCG remission, risk of developing postmolar GTN and proportion of women with high FIGO risk score. No relationship was observed between HC use with mean time to hCG remission (HC users versus non-users: 12 weeks in both, P = 0.19), GTN development (HC users versus non-users: 20.1 and 16.7%, P = 0.26) or high-risk FIGO score (HC users versus nonusers: 0% and 8%, P = 0.15). Moreover, no association between HC and GTN development was found, even when an age-adjusted model was used (OR = 1.37, 95% CI 0.91-2.08, P = 0.13). The use of current HC is not associated with development of postmolar GTN or delayed time to hCG remission. Therefore, HC can be safely used to prevent a new conception following CHM regardless of hCG level. Non-concurrent cohort study to re-evaluate the safety of low dose HCs after uterine evacuation of CHM.

Indústria frigorífica halal no Brasil, mão-de-obra islamita e estado de exceção

In the last decade, Brazilian meat export rates for Muslim religious countries have increased, and also has the immigration of Africans workers able to perform the slaughter following the precepts of Islam - religion that has expanded in the world, and thus, has the halal food segment. Halal, the Islamic ideology, means lawful, authorized by God: are those products that Allah in the Holy Qur'an releases for human consumption. To get halal certification some measures during slaughter/processing food should be taken. In the case of the slaughterhouses the animal must be slaughtered by a Muslim. Consequently, the demand for this skilled labor makes many African-Muslims get jobs in factories owned by BRF Foods, JBS and Marfrig; refugees and with their citizenship rights committed, these individuals live in a socio-political state of exception and overexploitation. In this study we intend to discuss the object of study Islamist workforce in Brazilian halal meat industry using the theoretical reflections of Giorgio Agamben (Homo Sacer in 2002, and State of Exception, 2004) and David Harvey (The Condition of Postmodernity, 2008, and The New Imperialism, 2004) to address the situation of immigrants in the meat business in Brazil, specially those on the halal certification segment, whose working and living conditions were described from academic studies and primary sources (articles in newspapers / magazines, websites, immigration official data). In addition we use the works of Rogério Heasbaert (O mito da desterritorialização, 2007) and Robert Kurz (Os paradoxos dos direitos humanos: inclusão e exclusão na modernidade, 2003) to discuss human mobility in this new century